RxDoctor Payments Data

Kim-Hien Dao, DO

Hematology · Salem, ORNPI 1770748121

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,380 of the $8,907 with a category attached, or 82.9%. Incyte Corporation accounts for 99.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $8,832 and has fallen 99.4% since, to $53 in 2024.

$8,907in general payments, 2019–2025

Across 20 payments — averaging $445.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$9K
  • Astellas Pharma US Inc$35
  • E.r. Squibb & Sons, L.L.C.$23
  • Acrotech Biopharma Inc.$18
$841,665in research payments, 2019–2025

Across 83 payments — averaging $10,141 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Incyte Corporation$687K
  • Otsuka Pharmaceutical Co., Ltd.$155K

What the payments were for

  • Consulting fees$7,38083%
  • Travel & lodging$1,04812%
  • Food & beverage$4805%

General payments by program year

19
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,907 in reported general payments places this provider in the 75th percentile of 27 hematology providers in Oregon.

See all hematology providers in Oregon

Medicare billing

Part B allowed, 2024
$18,561
Medicare patients
14
Services billed
490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Salem

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →